high
long
incub
period
short
serial
interv
gener
low
cfr
much
higher
patient
comorbid
spike
protein
bind
may
explain
high
autopsi
show
exud
lesion
less
fibrosi
consolid
remdesivir
chloroquin
tocilizumab
convalesc
plasma
may
effect
abstract
background
rapid
spread
coronaviru
diseas
caus
zoonot
betacoronaviru
entitl
novel
coronaviru
becom
global
threat
awar
biolog
featur
updat
time
need
comprehens
summar
help
optim
control
measur
make
therapeut
decis
method
base
recent
publish
literatur
offici
document
select
uptod
preprint
studi
review
virolog
origin
epidemiolog
clinic
manifest
patholog
treatment
infect
comparison
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
result
genom
partial
resembl
sarscov
merscov
indic
bat
origin
gener
high
reproduct
number
long
incub
period
short
serial
interv
low
case
fatal
rate
much
higher
patient
comorbid
sar
mer
clinic
present
patholog
greatli
resembl
sar
mer
less
upper
j
u
r
n
l
p
r
e
p
r
f
respiratori
gastrointestin
symptom
exud
lesion
postmortem
potenti
treatment
includ
remdesivir
chloroquin
tocilizumab
convalesc
plasma
vaccin
immun
possibl
conclus
initi
experi
current
pandem
lesson
previou
two
pandem
help
improv
futur
prepared
plan
combat
diseas
progress
late
decemb
pneumonia
outbreak
unknown
etiolog
took
place
wuhan
hubei
provinc
china
spread
quickli
nationwid
chines
center
diseas
control
prevent
ccdc
identifi
novel
betacoronaviru
call
offici
known
sever
acut
respiratori
syndrom
coronaviru
gorbalenya
et
al
respons
pandem
third
zoonot
coronaviru
breakout
first
two
decad
st
centuri
allow
humantohuman
transmiss
rais
global
health
concern
chines
govern
taken
immedi
transpar
extraordinari
measur
reach
initi
achiev
control
outbreak
march
pandem
pubm
web
scienc
embas
cnki
wanfang
vip
preprint
biorxiv
medrxiv
databas
earliest
avail
date
march
initi
search
term
novel
coronaviru
corona
viru
diseas
ncp
novel
coronaviru
pneumonia
search
word
keyword
sar
sarscov
sever
acut
respiratori
syndrom
mer
merscov
middl
east
respiratori
syndrom
combin
spike
protein
genom
reproduct
number
incub
period
serial
interv
fatal
rate
clinic
characterist
patholog
autopsi
treatment
j
u
r
n
l
p
r
e
p
r
f
moreov
offici
document
news
releas
nation
health
commiss
pr
china
ccdc
cdc
usa
access
uptod
inform
articl
english
chines
consid
review
highlight
pandem
potenti
patholog
indic
emerg
coronaviru
comprehens
systemat
summar
uptod
knowledg
biolog
characterist
includ
virolog
origin
epidemiolog
clinic
manifest
patholog
treatment
natur
structur
biolog
featur
bind
receptor
host
cell
spike
protein
may
play
essenti
role
diseas
spread
summar
four
avail
patholog
studi
biopsi
autopsi
compar
result
previou
two
deadli
coronaviru
diseas
new
therapeut
measur
emerg
one
anoth
potenti
effect
treatment
remdesivir
chloroquin
tocilizumab
convalesc
plasma
vaccin
immun
possibl
evidencebas
medicin
alway
advoc
guid
clinic
decis
coronaviru
belong
subfamili
orthocoronavirina
famili
coronavirida
order
nidoviral
mainli
caus
infect
respiratori
gastrointestin
tract
novel
envelop
betacoronaviru
singl
strand
posit
sens
rna
genom
concern
origin
viru
sever
phylogenet
analysi
suggest
bat
probabl
anim
reservoir
base
genom
sequenc
ident
bat
ident
human
sarscov
merscov
chan
et
al
lu
et
al
sarscov
merscov
transmit
bat
palm
civet
dromedari
camel
final
human
anoth
anim
repres
intermedi
host
bat
human
pangolin
suggest
possibl
intermedi
host
genom
approxim
similar
repres
two
sublineag
phylogenet
tree
one
extrem
close
relat
lam
et
al
research
suggest
recombin
viru
bat
coronaviru
j
u
r
n
l
p
r
e
p
r
f
snake
coronaviru
comparison
conjunct
rel
synonym
codon
usag
bia
among
differ
anim
speci
ji
et
al
truth
yet
discov
spike
surfac
glycoprotein
coronaviru
play
essenti
role
bind
receptor
host
cell
determin
host
tropism
spike
protein
sprotein
report
bind
angiotensinconvert
enzym
receptor
sarscov
invad
host
cell
wherea
merscov
use
dipeptidyl
peptidas
primari
receptor
amino
acid
sequenc
anoth
research
team
also
discov
rrar
furin
recognit
site
insert
proteas
cleavag
site
instead
singl
arginin
sarscov
quantifi
kinet
mediat
interact
via
surfac
plasmon
reson
calcul
bind
ectodomain
nm
affin
approxim
higher
affin
bind
sarscov
wrapp
et
al
bind
affin
sprotein
compar
even
stronger
sarscov
sprotein
may
explain
rapid
develop
strong
abil
humantohuman
transmiss
pandem
escal
exponenti
begin
might
tip
iceberg
due
delay
case
report
defici
test
kit
onset
first
cluster
case
report
exposur
histori
j
u
r
n
l
p
r
e
p
r
f
huanan
seafood
wild
anim
wholesal
market
wuhan
howev
phyloepidemiolog
analys
suggest
huanan
market
origin
viru
import
elsewher
boost
crowd
market
yu
et
al
proport
infect
case
without
exposur
histori
health
care
worker
gradual
increas
evid
indic
humantohuman
transmiss
abil
may
alreadi
spread
silent
peopl
wuhan
cluster
case
huanan
market
discov
late
decemb
persontoperson
transmiss
may
occur
mainli
droplet
contact
transmiss
accord
guan
latest
pilot
studi
detect
posit
gastrointestin
tract
specimen
stool
rectal
swab
well
saliva
urin
even
esophag
eros
bleed
site
sever
peptic
ulcer
patient
four
import
epidemiolog
paramet
review
comparison
sarscov
merscov
shown
tabl
repres
averag
number
new
infect
gener
infecti
person
total
popul
number
infect
like
increas
transmiss
like
declin
die
reproduct
number
updat
along
develop
outbreak
intervent
estim
around
sar
bauch
et
al
mer
bauch
orabi
preliminari
report
sever
research
group
report
estim
outbreak
depend
distinct
estim
method
valid
underli
assumpt
liu
et
al
review
refer
estim
rang
mean
median
clinic
studi
studi
januari
report
approxim
ci
anoth
studi
januari
estim
ci
discrep
may
due
sampl
number
differ
stage
pandem
incub
period
defin
interv
initi
exposur
infecti
agent
onset
symptom
sign
caus
long
incub
period
may
lead
high
rate
asymptomat
subclin
infect
first
predict
mean
incub
period
day
ci
day
percentil
distribut
day
base
exposur
histori
first
case
wuhan
studi
report
day
interquartil
rang
j
u
r
n
l
p
r
e
p
r
f
day
anoth
studi
calcul
mean
incub
period
day
ci
day
use
known
travel
histori
wuhan
symptom
onset
date
backer
et
al
literatur
lay
foundat
set
day
medic
observ
period
exposur
occur
latest
studi
collect
case
hospit
provinc
china
declar
median
incub
period
day
rang
surprisingli
day
adjust
screen
control
polici
may
need
gener
longer
incub
time
sarscov
day
ci
day
lessler
et
al
merscov
rang
day
park
et
al
serial
interv
interv
ill
onset
primari
case
ill
onset
secondari
case
mean
serial
interv
estim
day
ci
use
contact
trace
data
earli
wuhan
case
pandem
shorter
mean
serial
interv
report
sar
lipsitch
et
al
mer
cowl
et
al
anoth
estim
mean
serial
interv
infectorinfecte
pair
surprisingli
day
shorter
median
incub
period
suggest
substanti
proport
secondari
transmiss
ill
onset
nishiura
et
al
cfr
earli
studi
involv
rel
small
sampl
confirm
case
wuhan
vari
huang
et
al
may
abl
reflect
truth
cfr
wuhan
undoubtedli
higher
cfr
outsid
wuhan
report
cfr
rang
larg
nationwid
case
studi
prognosi
factor
male
elderli
patient
year
underli
diseas
sever
pneumonia
baselin
delay
onset
diagnosi
day
substanti
elev
cfr
cfr
patient
cardiovascular
diseas
diabet
hypertens
respiratori
disord
high
respect
accord
announc
sar
account
case
death
cfr
clinic
present
greatli
resembl
viral
pneumonia
sar
mer
case
mild
case
whose
symptom
usual
selflimit
recoveri
two
week
wu
mcgoogan
sever
patient
progress
rapidli
acut
respiratori
distress
syndrom
ard
septic
shock
eventu
end
multipl
organ
failur
gener
inform
four
inpati
case
studi
rel
comprehens
data
summar
supplementari
tabl
like
infect
elderli
men
comorbid
male
suscept
infect
sarscov
merscov
studi
badawi
ryoo
due
x
chromosom
sex
hormon
role
innat
adapt
immun
jaillon
et
al
chronic
underli
diseas
mainli
hypertens
cardiocerebrovascular
diseas
diabet
may
increas
risk
infect
similar
merscov
infect
badawi
ryoo
smoke
may
neg
prognost
indic
guan
et
al
clinic
inform
four
select
inpati
case
studi
summar
supplementari
tabl
onset
symptom
usual
mild
nonspecif
present
fever
dri
cough
short
breath
patient
promin
upper
respiratori
tract
gastrointestin
symptom
eg
diarrhea
huang
et
al
compar
patient
merscov
sarscov
infect
develop
diarrhea
assiri
et
al
howev
patient
initi
present
fever
develop
follow
hospit
compar
high
frequent
sarscov
merscov
infect
badawi
ryoo
patient
without
fever
even
asymptomat
may
left
unquarantin
silent
infect
sourc
surveil
method
focus
heavili
j
u
r
n
l
p
r
e
p
r
f
fever
detect
moreov
onset
symptom
may
help
physician
identifi
patient
poor
prognosi
patient
admit
icu
like
report
pharyng
pain
dyspnea
dizzi
abdomin
pain
anorexia
term
laboratori
find
substanti
decreas
total
number
lymphocyt
could
use
index
diagnosi
infect
indic
consumpt
immun
cell
impair
cellular
immun
function
nonsurvivor
develop
sever
lymphopenia
time
initi
proinflammatori
plasma
cytokin
concentr
higher
patient
healthi
adult
icu
patient
even
higher
plasma
level
gscf
compar
nonicu
patient
numer
differ
laboratori
find
patient
admit
icu
includ
higher
white
blood
cell
neutrophil
count
higher
level
ddimer
creatin
kinas
creatin
icu
patient
typic
chest
ct
manifest
pneumonia
initi
small
subpleur
ground
glass
opac
grew
larger
crazypav
pattern
consolid
two
week
growth
lesion
gradual
absorb
leav
extens
opac
subpleur
parenchym
band
recoveri
patient
howev
guan
et
al
demonstr
patient
normal
radiolog
find
initi
present
consist
sever
nonsever
case
respect
add
complex
diseas
control
nichol
et
al
thrombi
seen
six
autopsi
sarscov
infect
patient
even
huge
thrombu
format
part
pulmonari
vessel
coagul
function
disord
report
sever
patient
elev
level
ddimer
prolong
prothrombin
time
end
dissemin
intravascular
coagul
huang
et
al
may
explain
sudden
death
clinic
recoveri
patient
serv
indic
diseas
sever
autopsi
studi
one
patient
without
usag
corticosteroid
demonstr
increas
lymphocyt
five
specimen
treat
corticosteroid
pei
et
al
suggest
inhibit
immun
system
similar
human
monoclon
antibodi
could
effici
neutral
sarscov
inhibit
syncytia
format
sprotein
express
cell
sui
et
al
appropri
modif
monoclon
antibodi
may
effect
treatment
potenti
therapi
target
reninangiotensin
system
increas
express
inhibit
ace
may
effect
antivir
treatment
coronaviru
infect
even
strong
candid
lopinavirritonavir
abidol
exhibit
remark
effect
clinic
improv
day
mortal
viru
clearanc
chen
et
al
expect
attent
shift
remdesivir
may
potenti
widespectrum
drug
antivir
treatment
remdesivir
adenosin
analogu
incorpor
novel
viral
rna
chain
result
prematur
termin
current
clinic
develop
treatment
ebola
viru
infect
mulangu
et
al
wang
et
al
reveal
remdesivir
highli
effect
safe
control
infect
vero
cell
cell
success
applianc
remdesivir
first
infect
case
unit
state
clinic
statu
get
worsen
recent
releas
holshu
et
al
anim
experi
also
show
superior
remdesivir
lopinavirritonavir
combin
reduc
merscov
titer
infect
mice
improv
lung
tissu
damag
sheahan
et
al
effect
safeti
remdesivir
expect
clinic
trial
lead
dr
bin
cao
infect
associ
cytokin
storm
trigger
overactiv
immun
system
xu
et
al
similar
sar
mer
aberr
excess
immun
respons
lead
longterm
lung
function
structur
damag
patient
surviv
icu
ongo
trial
antagonist
tocilizumab
shown
effect
cytokin
releas
syndrom
result
cart
cell
infus
b
cell
acut
lymphoblast
leukemia
may
expand
restor
cell
count
treat
sever
infect
le
et
al
avail
observ
studi
metaanalysi
corticosteroid
treatment
suggest
impair
antibodi
respons
increas
mortal
secondari
infect
rate
influenza
increas
viraemia
impair
viru
clearanc
sarscov
merscov
complic
corticosteroid
therapi
survivor
zumla
et
al
therefor
corticosteroid
recommend
treatment
use
sever
patient
special
caution
review
nichol
et
al
conclus
still
remain
challeng
task
fight
unknown
origin
mysteri
biolog
featur
control
outbreak
high
long
incub
period
short
serial
interv
limit
treatment
prevent
measur
lesson
learn
mer
sar
outbreak
provid
valuabl
insight
handl
current
pandem
success
public
health
outbreak
respons
tactic
chines
govern
hand
hygien
wear
mask
isol
quarantin
social
distanc
commun
contain
copi
countri
accord
nation
situat
pandem
still
ongo
expand
experi
research
literatur
china
countri
increas
monitor
possibl
gene
variat
antigen
drift
antigen
convers
avoid
anoth
round
outbreak
anoth
lesson
pandem
awe
natur
love
life
fund
sourc
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
ethic
approv
ethic
approv
individu
consent
applic
author
declar
conflict
interest
author
nt
financi
person
relationship
peopl
organ
could
influenc
work
